echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Science: COVID19 neutral antibodies show therapeutic potential

    Science: COVID19 neutral antibodies show therapeutic potential

    • Last Update: 2020-06-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , June 16, 2020 /--- PRNewswire/ -- In a recent study, researchers at the Scripps Institute tested animal and human cells and found that antibodies in the blood of recovered COVID-19 patients provided strong protection against SARS-CoV-2the results, published recently in the journal Science, laid the groundwork for clinical trials and additional tests on antibodiesat present, the treatment or vaccine development for severe COVID-19 is the most important health problem in the worldGlobally, nearly 8 million people have tested positive for SARS-CoV-2 infection, and 400,000 people have died, and the number of new infections is still rising every day(photo:one way to address the new virus threat is to identify antibodies in the blood of recovered patients that have the ability to neutralise the virusauthors Rogers et altook blood samples from patients recovering from mild to severe COVID-19At the same time, Scripps Research and IAVI scientists have collaborated to develop cells that express ACE2In a preliminary set of experiments, the team tested whether blood samples from patients could bind to the virus and prevent infected cellsAfter, the scientists isolated more than 1,000 different antibody-producing B-cells, and obtained a sequence of antibody genes from those B cells so that antibodies could be produced in the labBy sifting through the antibodies individually, the team identified several candidates that could block the virusall of this work - including the development of cell and animal infection models, as well as studies of the location of target antibodies and viral bindings - was done in less than seven weeksIf further animal safety trials and human clinical trials go well, it could be used in clinical practice as early as January next year, the researchers said(Bio Valley Bioon.com)source: Super-potent human antibodies against coVID-19 in animal tests
    original source: Thomas F Rogers et al.
    Isolation of the potent SARS-CoV-2 neutralizing anti anti and protection from disease in a animal small model model.
    Science 15 Jun 2020, DOI: 10.1126/science.abc7520, science.sciencemag.org/content .. 6/15/science.abc7520
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.